Eduardo Bush

Eduardo Bush serves as a key procurement professional within the Naval Medical Research Unit South (N44852), supporting the agency’s mission to enhance military medical readiness through applied research in tropical and infectious diseases. Responsible for managing acquisitions aligned with field-deployable diagnostics, entomological surveillance, and biothreat detection systems, Bush ensures that contracting activities directly enable scientific operations critical to expeditionary force protection. His work spans the full lifecycle of service-based contracts, from requirement development to contract closeout, with a focus on enabling rapid response capabilities in high-threat environments. While no specific contractor relationships are currently documented, Bush’s procurement activity is centered on engaging a broad spectrum of scientific and technical service providers, including research laboratories, field equipment specialists, and diagnostic solution developers. His contracting patterns reflect a preference for flexible, non-traditional vendor partnerships that can rapidly adapt to evolving operational needs in austere settings, often involving agile acquisition methods such as Other Transaction Authorities or basic ordering agreements. Bush’s procurement portfolio exhibits a 100% preference for non-set-aside contracts, indicating a primary emphasis on technical capability and mission urgency over socioeconomic classifications. This approach prioritizes speed, expertise, and scalability in response to dynamic field conditions, with limited use of 8(a), HUBZone, or SDVOSB set-asides, though small business participation is not excluded when competitive and mission-aligned. The agency’s sole NAICS focus is 561990 (All Other Support Services), reflecting a heavy reliance on specialized scientific and technical support services. These include vector monitoring, laboratory diagnostics, biocontainment support, and field-deployable analytical systems. Bush’s expertise lies in procuring high-precision, research-enabling services that bridge operational medicine with cutting-edge biological threat mitigation, ensuring naval forces remain protected from region-specific infectious disease risks.